In Reply We thank Zhang and Xu and Lien et al for their thoughtful comments on our recent article examining fracture risk prediction in individuals with cancer. Cancer therapies and outcomes have indeed evolved over the observation period of our study. Although stratifying our analysis for different time periods would be interesting, performing validation studies… Continue reading Improving the Clinical Utility of FRAX in Patients With Cancer—The Need for More Detailed Analysis—Reply
Tag: Cancer Prevention and Screening
Improving the Clinical Utility of FRAX in Patients With Cancer—The Need for More Detailed Analysis
To the Editor We commend Ye et al for their comprehensive analysis of fracture risk using the Fracture Risk Assessment Tool (FRAX) in individuals with cancer. This study provides valuable insights into fracture risk among patients with cancer, an area that warrants attention due to the unique health challenges faced by this population. However, several… Continue reading Improving the Clinical Utility of FRAX in Patients With Cancer—The Need for More Detailed Analysis
Improving the Clinical Utility of FRAX in Patients With Cancer—The Need for More Detailed Analysis
To the Editor We recently read the article by Ye et al with great interest. This study contributes significantly to understanding the utility of the Fracture Risk Assessment Tool (FRAX) in predicting fracture risk among patients with cancer, an area with substantial clinical importance given the heightened vulnerability of this population. Although the study contributes… Continue reading Improving the Clinical Utility of FRAX in Patients With Cancer—The Need for More Detailed Analysis
Stress: A New Cancer Risk Factor?
Even everyday stress, the kind that many people experience, impairs the cancer-fighting immune system. Medscape
Cerebral Venous Thrombosis Linked to Increased Cancer Risk
The risk for cancer increases after cerebral venous thrombosis, especially in men older than 50 years; a new study calls for routine cancer screening in these patients. Medscape News UK
Toward improved early detection of pancreatic cancer
Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis. Early detection of PC is the primary concern of most PC research, as it has the potential to make a substantial difference to the treatment and survival… Continue reading Toward improved early detection of pancreatic cancer
Researchers identify DNA changes, biological pathways associated with inherited cancer risk
Stanford Medicine researchers sifted through thousands of single nucleotide mutations in DNA to identify fewer than 400 that are functionally associated with inherited cancer risk.
Landmark atlas reveals how aging breast tissue shapes breast cancer risk
Aging is a privilege, but it also brings risks — including an increased likelihood of developing age-related diseases including cancer. Researchers have now created a landmark atlas of how healthy breast tissue ages, revealing key cellular, molecular, and genetic changes that may tip the balance toward breast cancer development.
Autoimmunity in Long-COVID
[News] Largest trial of AI in breast cancer screening launched
The UK’s National Health Service (NHS) has launched the world’s largest prospective trial of using artificial intelligence (AI) to assess routine mammogram screenings. Nearly 700 000 women who have booked routine screenings in the UK will be invited to participate from April, 2025.